Two patients receiving PEIDF had unsatisfactory outcomes: one patient with end-stage renal disease suffered from an uneven decline of CRP postoperatively and experienced a sepsis episode during hospitalization; the other patient with a preoperative traumatic subdural hemorrhage encountered a sudden onset subarachnoid hemorrhage in the intensive care unit about one month postoperatively. This evidence concerns the gene CRP and chronic kidney disease.